Uterine Fibroids: Symptoms, Fertility and Treatment Options

Uterine fibroids are benign growths arising from the muscle of the uterus. They may occur as one growth or several and can sit within the uterine wall, project toward the outer surface or alter the uterine cavity. Many are discovered incidentally and cause no symptoms. Their presence does not by itself mean cancer, infertility or a need for surgery.

Location, size and number help explain potential effects, but symptoms and life goals are equally important. A small fibroid that changes the cavity may have different relevance from a larger one on the outside of the uterus. Treatment decisions should not rely on diameter alone.

Fibroids can be associated with heavy or prolonged periods, bleeding between periods, menstrual cramps, pelvic pressure, urinary frequency, constipation, abdominal enlargement or pain during sex. These symptoms overlap with adenomyosis, endometriosis, polyps and other conditions, so assessment should not assume fibroids explain each complaint.

Track bleeding, cycle timing, pain and how symptoms affect daily life. Very heavy bleeding with weakness, faintness or breathlessness, acute severe pain, fever or pregnancy-related bleeding needs prompt assessment. A change in fibroid size can justify review, but rapid growth alone is not a diagnosis of cancer and should not be used for alarming comparisons with sarcoma.

Repeated heavy bleeding can lead to iron deficiency and anaemia. Fatigue, breathlessness, palpitations, dizziness or reduced exercise tolerance may be clues, although blood testing is needed for diagnosis. A full blood count is commonly part of assessment when heavy menstrual bleeding is reported.

Care may need to address bleeding and iron deficiency at the same time. Iron treatment does not identify the cause of bleeding, and controlling bleeding does not immediately restore iron stores. Severe symptoms or very low blood count may need urgent or specialist management.

Assessment begins with menstrual, pregnancy and medical history and may include abdominal or pelvic examination. Ultrasound is commonly used to identify fibroid size, number and location and to assess the ovaries and uterus. The route of ultrasound depends on symptoms, suitability and consent.

If cavity distortion is suspected, hysteroscopy or specialized imaging may be considered. MRI is useful in selected complex cases or procedure planning but is not routinely required. Investigations should answer a clinical question and support a decision rather than simply produce a longer list of findings.

Most fibroids do not prevent pregnancy. Fertility relevance depends particularly on whether a fibroid distorts the uterine cavity, along with size, location and other fertility factors. Sperm, ovulation, tubes, age and endometriosis should still be considered before assigning the delay to a fibroid.

During pregnancy, many people with fibroids have uncomplicated outcomes, while some have pain, fetal-position issues or other complications. Preconception treatment is not required for each fibroid. Surgery can also affect the uterus and future birth planning, so potential benefits and risks deserve careful discussion.

Observation may be appropriate when fibroids cause little difficulty, the diagnosis is clear and there is no concerning change. Follow-up is based on symptoms, life stage and clinical findings rather than a fixed scan schedule for each person. Fibroids often change around menopause, but new bleeding still needs appropriate evaluation.

Medicines may reduce heavy bleeding or pain and may include non-hormonal or hormonal options depending on contraception needs and medical history. Some medicines temporarily reduce fibroid-related symptoms or size. They do not suit each person, and the effect may not continue after treatment stops.

Procedure options may include hysteroscopic treatment for selected cavity fibroids, uterine-artery procedures, myomectomy that removes fibroids while preserving the uterus, or hysterectomy. Availability and suitability depend on symptoms, anatomy, fertility plans, age, previous treatment and local expertise.

Ask how the option may affect bleeding, pain, fertility, recurrence, recovery and future pregnancy. No procedure is automatically necessary because a fibroid was seen on ultrasound. The chosen plan should address the person’s main concern while avoiding treatment burden that is unlikely to help.

Myomectomy can preserve the uterus but does not prevent new fibroids from developing. The surgical route depends on fibroid location, number, size and surgeon assessment. Future pregnancy timing and mode of birth may need discussion after uterine surgery. Obtain a copy of the operation record for later obstetric care.

Uterine-artery procedures and other minimally invasive options may reduce symptoms for selected people, but fertility implications require careful counselling. Hysterectomy ends the possibility of carrying a pregnancy and is a major decision even when symptoms are severe. Consent should include alternatives and recovery expectations.

When symptoms are manageable, shared decision-making may lead to observation. A plan should state which changes prompt reassessment, such as heavier bleeding, increasing pressure, fertility plans or postmenopausal bleeding. Monitoring should serve the person’s goals rather than create repeated scans without a decision attached.